GH Research (GHRS) Assets (2021 - 2025)
GH Research's (GHRS) quarterly Assets came in at $288.2 million in Q4 2025, up 53.09% year-on-year from $188.3 million in Q4 2024, and down 4.57% quarter-over-quarter from $302.0 million in Q3 2025.
GH Research (GHRS) Assets (2021 - 2025) Analysis & Trends
GH Research's Assets history runs 5 years deep, the most recent figure standing at $288.2 million for Q4 2025.
- On a quarterly basis, Assets rose 53.09% year-over-year to $288.2 million in Q4 2025; TTM through Dec 2025 was $288.2 million, a 53.09% increase from a year earlier, with the FY2025 full-year figure at $288.2 million, up 53.09% from the prior year.
- Assets eased to $288.2 million in Q4 2025 per GHRS's latest filing, from $302.0 million in the prior quarter.
- Across five years, Assets topped out at $320.5 million in Q1 2025 and bottomed at $188.3 million in Q4 2024.
- The 5-year median for Assets is $257.2 million (2022), against an average of $256.3 million.
- Across the five-year window, Assets decreased 16.8% in 2024 and surged 53.09% in 2025, its largest moves.
- Year by year, Assets stood at $288.1 million in 2021, then slipped by 11.71% to $254.4 million in 2022, then declined by 11.03% to $226.3 million in 2023, then declined by 16.8% to $188.3 million in 2024, then jumped by 53.09% to $288.2 million in 2025.
- Per Business Quant, the three latest GHRS Assets figures stand at $288.2 million (Q4 2025), $302.0 million (Q3 2025), and $313.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | 288.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 288.23 Mn |
| Sep 30, 2025 | 302.02 Mn |
| Jun 30, 2025 | 313.43 Mn |
| Mar 31, 2025 | 320.45 Mn |
| Dec 31, 2024 | 188.27 Mn |
| Sep 30, 2024 | 199.61 Mn |
| Jun 30, 2024 | 206.98 Mn |
| Mar 31, 2024 | 217.58 Mn |
| Dec 31, 2023 | 226.30 Mn |
| Sep 30, 2023 | 232.57 Mn |
| Jun 30, 2023 | 240.27 Mn |
| Mar 31, 2023 | 249.26 Mn |
| Dec 31, 2022 | 254.36 Mn |
| Sep 30, 2022 | 260.12 Mn |
| Jun 30, 2022 | 266.32 Mn |
| Mar 31, 2022 | 273.54 Mn |
| Dec 31, 2021 | 288.11 Mn |
| Sep 30, 2021 | 285.63 Mn |